Yellow fever (YF) virus is a member of the genus Flavivirus of the family Flaviviridae (Chambers et al., 1990 ; Monath, 1995) . The RNA genome of YF virus is 10 862 nt in length, single-stranded, positive-sense in polarity, capped at the 5h terminus and lacks a poly(A) tract at the 3h terminus (Deubel et al., 1983 ; Rice et al., 1985). A single large open reading frame encodes three structural proteins (core, membrane and envelope) and eight non-structural proteins (NS1-NS5) (Chambers et al., 1990) .
The 17D-204 vaccine manufactured in South Africa (17D-204-SA) and a large plaque variant (17D-LP) derived from it were highly virulent in adult mice. The LD 50 of 17D-LP virus was 0n2 p.f.u. for mice following intracerebral inoculation. In comparison, a medium plaque variant derived from 17D-LP, termed 17D-MP virus, was found to be attenuated in adult mice following the same route of inoculation ( 10 4 p.f.u./LD 50 ). Replication of 17D-MP virus was decreased in infected mouse brains compared to 17D-LP virus. Also, 17D-MP virus was slightly temperature sensitive at 39n5 mC. Compared to its parent viruses, 17D-204-SA and 17D-LP, 17D-MP virus had one unique mutation at nt 8045 in the genome which resulted in a single amino acid substitution (Pro Ser) at residue 137 of the NS5 protein and appeared to be the mutation responsible for the attenuation of 17D-MP virus. This is the first time that altered virulence of a flavivirus caused by mutation in a non-structural protein gene, other than NS1, has been reported.
Yellow fever (YF) virus is a member of the genus Flavivirus of the family Flaviviridae (Chambers et al., 1990 ; Monath, 1995) . The RNA genome of YF virus is 10 862 nt in length, single-stranded, positive-sense in polarity, capped at the 5h terminus and lacks a poly(A) tract at the 3h terminus (Deubel et al., 1983 ; Rice et al., 1985) . A single large open reading frame encodes three structural proteins (core, membrane and envelope) and eight non-structural proteins (NS1-NS5) (Chambers et al., 1990) .
The live attenuated YF vaccine 17D is one of the safest and most efficacious viral vaccines in use today. The 17D vaccine has been shown to contain a mixture of virions which can be distinguished by a number of criteria. Virions of small, medium and large plaque morphologies have been identified in vaccine doses, although the large plaque phenotype is the predominant virion in the vaccine population (Liprandi, 1981) . These plaque size variants can be distinguished biologically by mouse neurovirulence (Liprandi, 1981 ; and replication in macrophages (Liprandi & Walder, 1983) , and with monoclonal antibodies in neutralization, passive protection and haemagglutination-inhibition tests (Buckley & Gould, 1985 ; Gould et al., 1986 ; Barrett et al., 1989 ; Ledger et al., 1992) . Three plaque size variants were isolated from the 17D-204 vaccine manufactured in England and differentiated by virulence for adult mice following intracerebral inoculation (Liprandi, 1981) . The small and large plaque variants were lethal for adult mice, whereas the medium plaque variant was attenuated and failed to kill mice at doses up to 10' p.f.u. The molecular basis for the attenuation of the medium plaque variant is unknown. In this paper, we report that a medium plaque variant derived from the 17D-204 vaccine manufactured in South Africa (17D-204-SA) is also attenuated for mice. To investigate the molecular basis of the attenuation of the medium plaque variant of 17D-204-SA virus, we have cloned and sequenced its entire genome, compared it to that of its parental viruses and demonstrated that the mutation is in the NS5 protein gene.
Vero cells and LLC-MK-2 cells were grown at 37 mC in Eagle's minimal essential medium (EMEM ; Sigma) supplemented with 5 % heat-inactivated foetal calf serum (Sigma), 2 mM -glutamine (Sigma) and antibiotics. The 17D-204-SA virus, batch 10802, was kindly provided by Thomas Monath of the Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, Colorado, USA. YF wildtype strains Peru-1 and -2 were isolated during an epidemic in Peru in 1995 (Wang et al., 1996) . Viruses were propagated in Vero cell monolayers infected at an m.o.i of approximately 0n1. Culture supernatant was harvested 6 days after infection at 37 mC. The virulence of viruses was investigated in two mouse strains : outbred NIH Swiss and inbred BALB\c (H-2 d ). Female mice, 3-4 weeks of age, were inoculated intracerebrally with either 2 000 or 10 000 p.f.u. of virus. Following inoculation, the animals were monitored daily for signs of infection. Virusinfected NIH Swiss and BALB\c mice were sacrificed at days 8, 11, 14, 23 and 30 post-infection. Virus infectivity titre in mouse brains was determined by plaque assay performed in Vero cell monolayers as described by Barrett et al. (1989) . Specific oligonucleotide primers used in cDNA synthesis and PCR were synthesized according to the known sequence of 17D-204-ATCC (Rice et al., 1985) . RT-PCR, molecular cloning and sequencing were performed as described by Wang et al. (1995) . Briefly, viruses were grown in Vero cell cultures and RNA was extracted from the cell culture fluid. Thirty-four oligonucleotide primers were designed based on the published sequence of 17D-204-ATCC vaccine virus (Rice et al., 1985) ( Table 1) . Reverse transcription of viral RNA involved incubation at 55 mC for 1-2 h with one of the 17 antisense primers and 1n8 U reverse transcriptase (RAV-2 ; Amersham). The resulting cDNA was denatured by heating to 94 mC for 5 min followed by PCR amplification involving 35 cycles of 52 mC for 40 s, 72 mC for 4 min and 94 mC for 40 s. PCR products were either directly sequenced in an Applied Biosystems model 377 automated sequencer or cloned using the TA cloning kit (Invitrogen) prior to sequencing. Computer analyses of nucleotide sequences and deduced amino acid sequence were performed using PCGENE (Intelligenetics) program, including the Novotny method for protein secondary structure predictions. Two plaque morphologies were identified after the 17D-204-SA vaccine virus was grown in LLC-MK-2 cells, a small plaque type (0n5-0n8 mm in diameter) and a large plaque type (1n8-2n0 mm in diameter), although the large plaque phenotype was predominant. A large plaque was selected from the vaccine population, amplified and plaque-purified twice in LLC-MK-2 cells as described by Ledger et al. (1992) . This virus was termed 17D-LP virus (LP, large plaque). Subsequently, the 17D-LP 17D-LP 17D-MP 17D-LP 17D-MP 8 5 n 3 3 n 0 5 n 3 4n1 5n6 4 n 3 5 n 4 4n3 5n7 5 n 0 4 n 5 5 n 3 4 n 6 11  4n3  4n0 4n4 4 n 0 4 n 7 14
virus was cloned in LLC-MK-2 cells by limited dilution and a variant, termed 17D-MP virus (MP, medium plaque), was identified on the basis that its plaque size (1n2 mm in diameter) was smaller than the parent 17D-LP virus but larger than the small plaque virus.
The 17D-LP virus was lethal for mice following intracerebral inoculation and had a LD &! of 0n2 p.f.u. in NIH Swiss mice and 10 p.f.u. in BALB\c mice. In contrast, the majority of mice survived infection by 10% p.f.u. of 17D-MP virus : 93n3 % (42\45) for NIH Swiss mice and 89n1 % (26\29) for BALB\c mice. Also, both strains of mice infected with 17D-LP virus died by day 9 post-infection, whereas 17D-MP virusinfected mice died only after day 11 post-inoculation. Approximately one-third of the surviving mice (13\42 NIH Swiss and 10\26 BALB\c) had hind-limb paralysis which appeared permanent as the same clinical signs were observed in mice at 1 year post-inoculation.
At day 8 post-inoculation, virus was detected in the brains of NIH Swiss and BALB\c mice infected with 17D-LP virus at a mean infectivity titre of 5n5p0n1 log "! p.f.u. per brain (Table  2) . For 17D-MP virus-infected NIH Swiss and BALB\c mice, infectious virus was detected at a significantly lower mean titre, 4n4p0n2 log "! p.f.u. per brain (Table 2) . Virus was detected in the brains of all 17D-MP virus-infected mice sampled at day 11 post-infection but not at later times.
17D-MP virus was temperature sensitive at 39n5 mC [efficiency of plaquing (e.o.p.) at 39n5 mC versus 37 mC was 0n06], whereas neither 17D-204-SA nor 17D-LP virus was temperature sensitive at 39n5 mC (e.o.p. l 0n2). No difference in the replication kinetics was observed between 17D-LP and 17D-MP viruses when they were grown in Vero cell monolayers at 37 mC (data not shown).
All strains of YF virus tested so far, including 17D vaccine strains, are lethal for adult mice following intracerebral inoculation (Fitzgeorge & Bradish, 1980 ; . However, two medium plaque variants, originating from different seeds of 17D-204 vaccines [England (Liprandi, 1981) and South Africa (this paper)], were attenuated and only killed a minority of mice at doses up to 10% p.f.u. In contrast, the large plaque variants of these two vaccine strains were lethal for mice following the same route of inoculation. Compared to 17D-204-SA vaccine virus, its medium plaque variant was at least 5i10%-fold more attenuated than the large plaque variant. Therefore, from these limited observations, the medium plaque variants of 17D-204 vaccine appear to be more attenuated for mice than the large plaque variants.
Comparison of the entire genomic nucleotide sequence, other than the 25 nt at the termini, of the 17D-MP virus with those of 17D-LP and 17D-204-SA viruses revealed one unique nucleotide difference at position 8045 (C U), which was confirmed by an independent RT-PCR followed by sequencing. Furthermore, three subsequent passages of 17D-MP resulted in the virus maintaining the medium plaque morphology, attenuation of mouse neurovirulence and the mutation at nt 8045. Thus, the phenotype and genotype appear stable. This nucleotide change resulted in a proline to serine substitution at residue 137 of the NS5 protein. This substitution altered the predicted secondary structure of the NS5 protein. Alignment of the amino acid sequences surrounding NS5-137 for several wild-type YF viruses, 17D vaccine viruses and several other flaviviruses revealed that this amino acid substitution was not seen in any 17D vaccine viruses nor in two wild-type YF strains [Asibi and French viscerotropic virus (FVV)] (Fig. 1) . Most flaviviruses (8 out of 13) also had a proline at this position while three flaviviruses had a serine and two had a threonine at this position. This indicates that proline is highly conserved among flaviviruses. Interestingly, two wild-type YF viruses (Peru-1 and -2) had a serine residue at NS5-137. However, these two strains also had three other amino acid substitutions at NS5-79 (Ile Thr), NS5-108 (Arg Lys) and NS5-109 (Asp Glu) which were not seen in 17D-MP or 17D-LP virus.
The NS5 protein in flaviviruses is believed to have two enzymatic functions : RNA-dependent RNA polymerase in the C-terminal domain (Tan et al., 1996) , and methyltransferase in the N-terminal domain (Koonin, 1993) . The latter enzyme is proposed to be involved in viral RNA capping, and subsequently in viral protein synthesis. The region containing NS5-137 is involved in the methyltransferase activity. The mutation at NS5-137 is predicted to cause a secondary structural change in the methyltransferase domain of the NS5 protein which may further induce a tertiary structural change in this protein and be in part responsible for the slight temperature sensitivity of 17D-MP virus at 39n5 mC. Consequently the enzymatic BIJH H. Xie and others H. Xie and others function of the NS5 protein may be affected, resulting in impaired viral RNA capping and synthesis of viral proteins, and decreased replication of 17D-MP virus in mouse brains because the virus can not multiply efficiently. Reduced replication of 17D-MP virus (Table 2 ) may explain the hindlimb paralysis seen in many 17D-MP virus-infected mice. Although we can not measure the temperature in the mouse brain directly, support for this proposal comes from examination of rectal temperatures of virus-infected BALB\c and NIH Swiss mice. Both 17D-LP and 17D-MP virus-infected mice had peak rectal temperatures at days 5, 6 and 7 postinfection of 38n5 mC (data not shown). Other than reduced replication of 17D-MP virus at 39n5 mC, we have found no evidence for reduced replication of 17D-MP virus compared to 17D-LP virus in Vero cell culture. Increased temperature of the infected mouse is considered the most likely candidate responsible for the attenuated phenotype. However, we cannot exclude the possibility that the mutation in NS5 alters the interaction of virus and host cell components of the virus replication complex.
It is also possible that NS5-137 is a part of a T cell epitope. This mutation at NS5-137 may lead to altered interaction of viral antigen with T lymphocytes, although to date no flavivirus T cell epitopes have been mapped to the NS5 protein.
Finally, non-structural proteins in flaviviruses have very important functions in virus replication (Chambers et al., 1990) . However, prior to this study, only mutations in the NS1 protein gene of flaviviruses have been demonstrated to affect virus multiplication and subsequently viral pathogenesis (Pletnev et al., 1992 ; Muylaert et al., 1996) . Mutations in the NS1 protein which ablated the first and both glycosylation sites impaired NS1 protein secretion, reduced mouse neurovirulence and decreased replication of YF virus (Muylaert et al., 1996) .
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